Psyence Group Inc
Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the h… Read more
Psyence Group Inc (PSYGF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.338x
Based on the latest financial reports, Psyence Group Inc (PSYGF) has a cash flow conversion efficiency ratio of -0.338x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-284.85K) by net assets ($843.69K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Psyence Group Inc - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Psyence Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Psyence Group Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Psyence Group Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nextage Therapeutics Ltd
TA:NXTG
|
0.311x |
|
TRUBF
PINK:TRUBF
|
0.090x |
|
Syncona Limited
LSE:SYNC
|
0.006x |
|
New Mountain Finance Corporation
NASDAQ:NMFC
|
0.018x |
|
Crossroads Systems Inc
OTCQX:CRSS
|
1.718x |
|
Margo Caribe Inc
PINK:MRGO
|
-0.012x |
|
Mercer Park Opportunities Corp Ordinary Shares - Class A (Restricted Voting
TO:SPAC-U
|
N/A |
|
TEEKAY
MU:TCD
|
0.058x |
Annual Cash Flow Conversion Efficiency for Psyence Group Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of Psyence Group Inc from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $9.54 Million | $-5.55 Million | -0.582x | -239.99% |
| 2024-03-31 | $-11.83 Million | $-4.92 Million | 0.415x | +115.22% |
| 2023-03-31 | $1.33 Million | $-3.64 Million | -2.729x | -107.86% |
| 2022-03-31 | $2.71 Million | $-3.56 Million | -1.313x | -134.82% |
| 2021-03-31 | $-12.26K | $-46.23K | 3.771x | +1031.60% |
| 2020-03-31 | $80.25K | $-32.48K | -0.405x | -436.29% |
| 2019-03-31 | $99.31K | $-7.50K | -0.075x | -168.93% |
| 2018-03-31 | $-114.89K | $-12.58K | 0.109x | -48.03% |
| 2017-03-31 | $-94.92K | $-20.00K | 0.211x | -- |